In order to identify a potentially increased vulnerability of psoriasis patients to COVID-19, we analyzed furin and ACE2 mRNA levels from blood cells in psoriasis patients prior to and during systemic biologic treatment or prior to and after topical dithranol treatment. This evidence concerns the gene FURIN and psoriasis.